Medibank Private Limited (ASX: MPL) is one of Australia’s largest private health insurers and a prominent player on the Australian Securities Exchange (ASX). Since its public listing in November 2014, Medibank shares have attracted considerable attention from investors due to the company’s strong market position and steady financial performance.
Current Share Price and Market Performance
As of May 19, 2025, Medibank’s share price was approximately $4.76 AUD, showing a slight increase of 0.42% on that day. Over the past year, Medibank shares have outperformed the ASX 200 index by about 25.6%, reflecting solid investor confidence and the company’s resilience in the health insurance sector.
Medibank’s market capitalization stands near $12.8 billion AUD, underscoring its significant presence in the Australian market.
Dividend History and Investor Returns
Medibank has a consistent history of paying fully franked dividends, which means shareholders receive tax credits for the tax already paid by the company. For example, the interim dividend paid on March 26, 2025, was 7.8 cents per share, and the final dividend for 2024 was 9.4 cents per share2. The company typically pays two dividends annually—interim and final—with a payout ratio around 86%, making it attractive for income-focused investors.
Company Overview
Medibank operates under two main brands—Medibank and ahm—offering private health insurance as well as virtual health, homecare, preventative health, and primary care services through its Amplar Health division, which includes Myhealth medical clinics. This diversification supports the core health insurance business and positions Medibank for future growth.
The company’s headquarters are located in Docklands, Victoria, and it is audited by PricewaterhouseCoopers.
Recent Share Price Trends
Medibank’s share price has shown relative stability with modest upward momentum in 2025. For instance, in mid-May 2025, the share price hovered between $4.71 and $4.77 AUD, indicating steady trading activity. Over the past 52 weeks, the share price has ranged from a low of approximately $3.53 to a high near $4.82, demonstrating resilience amid market fluctuations.
Analyst Outlook
Market analysts generally view Medibank as a stable investment in the healthcare sector, with forecasts suggesting moderate share price growth aligned with the company’s earnings and dividend outlook. The steady dividend yield and strong market position make it appealing for both growth and income investors.
Summary
Medibank Private Limited’s shares represent a solid investment option within Australia’s healthcare industry. With a current share price near $4.76 AUD, a strong dividend history, and consistent market performance, Medibank continues to be a key player on the ASX. Investors looking for exposure to the private health insurance sector often consider Medibank for its stability, reliable income, and growth potential.